PDCD1 and head and neck cancer: Immune checkpoint inhibitors (i.e., inhibitors of programmed cell death protein 1 [PD-1]) have had a major impact on the treatment of many solid tumors and now "have found their way into head and neck cancer," noted Dr. Haddad.